Preparation and characterization of fluorinated porcine hydroxyapatite
Source abstract
Abstract
Simple chemical and thermal treatments were applied to prepare fluorinated porcine hydroxyapatite (FPHA). Morphology of FPHA was observed using SEM. Physiochemical characteristics, namely crystalline phase, chemical composition, functional groups, and binding energy of fluorine were investigated using XRD, EDX, FTIR, and XPS respectively. Concentration of free fluoride ion released from FPHA in HCl solution (pH 3.0-4.0) was detected using a fluoride ion concentration meter. SEM, XPS, XRD, and FTIR results confirmed the fluorination of porcine hydroxyapatite (PHA). Significant crystal morphological difference was observed between PHA and FPHA. Concentration of free fluoride ion released from FPHA increased with rising concentration of immersion solution and length of immersion period. Fluoride was successfully incorporated into PHA by chemical and thermal processes in this study. Fluoride incorporation rate into PHA was a strong function of the fluorine concentration in the immersion solution.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental materials and restorations · Fluoride Effects and Removal
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. 1) Hallman M, Hedin M, Sennerby L, Lundgren S. A prospective 1-year clinical and radiographic study of implants placed after maxillary sinus floor augmentation with bovine hydroxyapatite and autogenous bone. J Oral Maxillofac Surg 2002; 60: 277-284; discussion 285-286.10.1053/joms.2002.30576 ↗
2. 2) Hallman M, Cederlund A, Lindskog S, Lundgren S, Sennerby L.A clinical histologic study of bovine hydroxyapatite in combination with autogenous bone and fibrin glue for maxillary sinus floor augmentation. Results after 6 to 8 months of healing. Clin Oral Implants Res 2001; 12: 135-143.10.1034/j.1600-0501.2001.012002135.x ↗
3. 3) Kannan S, Rocha JH, Agathopoulos S, Ferreira JM. Fluorinesubstituted hydroxyapatite scaffolds hydrothermally grown from aragonitic cuttlefish bones. Acta Biomater 2007; 3: 243-249.10.1016/j.actbio.2006.09.006 ↗
4. 4) Hallman M, Sennerby L, Lundgren S. A clinical and histologic evaluation of implant integration in the posterior maxilla after sinus floor augmentation with autogenous bone, bovine hydroxyapatite, or a 20:80 mixture. Int J Oral Maxillofac Implants 2002; 17: 635-643.
5. 5) Pearce AI, Richards RG, Milz S, Schneider E, Pearce SG. Animal models for implant biomaterial research in bone: a review. Eur Cell Mater 2007; 13: 1-10.10.22203/eCM.v013a01 ↗
6. 6) Spence G, Patel N, Brooks R, Rushton N. Carbonate substituted hydroxyapatite: resorption by osteoclasts modifies the osteoblastic response. J Biomed Mater Res A 2009; 90: 217-224.10.1002/jbm.a.32083 ↗
7. 7) Landi E, Tampieri A, Celotti G, Sprio S, Sandri M, Logroscino G.Sr-substituted hydroxyapatites for osteoporotic bone replacement. Acta Biomater 2007; 3: 961-969.10.1016/j.actbio.2007.05.006 ↗
8. 8) Landi E, Sprio S, Sandri M, Celotti G, Tampieri A. Development of Sr and CO3 co-substituted hydroxyapatites for biomedical applications. Acta Biomater 2008; 4: 656-663.10.1016/j.actbio.2007.10.010 ↗
9. 9) Kim HW, Koh YH, Kong YM, Kang JG, Kim HE. Strontium substituted calcium phosphate biphasic ceramics obtained by a powder precipitation method. J Mater Sci Mater Med 2004; 15: 1129-1134.10.1023/B:JMSM.0000046395.76435.60 ↗
10. 10) Ito A, Ojima K, Naito H, Ichinose N, Tateishi T. Preparation, solubility, and cytocompatibility of zinc-releasing calcium phosphate ceramics. J Biomed Mater Res 2000; 50: 178-183.10.1002/(SICI)1097-4636(200005)50:2<178::AID-JBM12>3.0.CO;2-5 ↗
11. 11) Jha LJ, Best SM, Knowles JC, Rehman I, Santos JD, Bonfield W. Preparation and characterization of fluoride-substituted apatites. J Mater Sci Mater Med 1997; 8: 185-191.10.1023/A:1018531505484 ↗
12. 12) Gibson IR, Bonfield W. Preparation and characterization of magnesium/carbonate co-substituted hydroxyapatites. J Mater Sci Mater Med 2002; 13: 685-693.10.1023/A:1015793927364 ↗
13. 13) Solla EL, Gonzalez P, Serra J, Chiussi S, Leon B, Lopez JG. Pulsed laser deposition of silicon substituted hydroxyapatite coatings from synthetical and biological sources. Appl Surf Sci 2007; 254: 1189-1193.10.1016/j.apsusc.2007.09.041 ↗
14. 14) Murugan R, Kumar TSS, Rao KP. Fluorinated bovine hydroxyapatite: preparation and characterization. Mater Lett 2002; 57: 429-433.10.1016/S0167-577X(02)00805-4 ↗
15. 15) Oktar FN, Agathopoulos S, Ozyegin LS, Gunduz O, Demirkol N, Bozkurt Y, Salman S. Mechanical properties of bovine hydroxyapatite (BHA) composites doped with SiO2 , MgO, Al2O3, and ZrO2. J Mater Sci Mater Med 2007; 18: 2137- 2143.10.1007/s10856-007-3200-9 ↗
16. 16) Kim YH, Kim SR, Jung SJ, Lee YJ, Song H. Silicon-substituted hydroxyapatite derived from coral. Euro Ceramics VIII 2004; 264-268: 1941-1944.10.4028/www.scientific.net/KEM.264-268.1941 ↗
17. 17) Taves DR. New approach to the treatment of bone disease with fluoride. Fed Proc 1970; 29: 1185-1187.
18. 18) Pak CY, Zerwekh JE, Antich P. Anabolic effects of fluoride on bone. Trends Endocrinol Metab 1995; 6: 229-234.10.1016/1043-2760(95)00111-T ↗
19. 19) Hui J, Xiang G, Xu X, Zhuang J, Wang X. Monodisperse F-substituted hydroxyapatite single-crystal nanotubes with amphiphilic surface properties. Inorg Chem 2009; 48: 5614- 5616.10.1021/ic900697b ↗
20. 20) Kimoto K, Okudera T, Okudera H, Nordquist WD, Krutchkoff DJ. Part I: crystalline fluorapatite-coated hydroxyapatite, physical properties. J Oral Implantol 2011; 37: 27-33.10.1563/AAID-JOI-D-09-00118.1 ↗
21. 21) Sogo Y, Ito A, Yokoyama D, Yamazaki A, LeGeros RZ. Synthesis of fluoride-releasing carbonate apatites for bone substitutes. J Mater Sci Mater Med 2007; 18: 1001-1007.10.1007/s10856-006-0092-z ↗
22. 22) Cacciotti I, Bianco A, Lombardi M, Montanaro L. Mgsubstituted hydroxyapatite nanopowders: Synthesis, thermal stability and sintering behaviour. J Eur Ceramic Soc 2009; 29: 2969-2978.10.1016/j.jeurceramsoc.2009.04.038 ↗
23. 23) Bianco A, Cacciotti I, Lombardi M, Montanaro L. Si- substituted hydroxyapatite nanopowders: Synthesis, thermal stability and sinterability. Mater Res Bull 2009; 44: 345-354.10.1016/j.materresbull.2008.05.013 ↗
24. 24) Murugan R, Ramakrishna S, Rao KP. Nanoporous hydroxycarbonate apatite scaffold made of natural bone. Mater Lett 2006; 60: 2844-2847.10.1016/j.matlet.2006.01.104 ↗
25. 25) Kurkcu M, Benlidayi ME, Ozsoy S, Ozyegin LS, Oktar FN, Kurtoglu C. Histomorphometric evaluation of implants coated with enamel or dentine derived fluoride-substituted apatite. J Mater Sci Mater Med 2008; 19: 59-65.10.1007/s10856-007-3167-6 ↗
26. 26) Kim SR, Lee JH, Kim YT, Jung SJ, Lee YJ, Song H, Kim YH. Bioactive behaviors of porous Si-substituted hydroxyapatite derived from coral. Bioceramics, 2004; 254-256: 969-972.10.4028/www.scientific.net/KEM.254-256.969 ↗
27. 27) Barrea RA, Perez CA, Ramos AY, Sanchez HJ, Grenon M. Distribution and incorporation of zinc in biological calcium phosphates. X-Ray Spectrometry 2003; 32: 387-395.10.1002/xrs.657 ↗
28. 28) Pak CY, Sakhaee K, Zerwekh JE, Parcel C, Peterson R, Johnson K. Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab 1989; 68: 150-159.10.1210/jcem-68-1-150 ↗
29. 29) Boivin G, Chavassieux P, Chapuy MC, Baud CA, Meunier PJ. Skeletal fluorosis: histomorphometric analysis of bone changes and bone fluoride content in 29 patients. Bone 1989; 10: 89-99.10.1016/8756-3282(89)90004-5 ↗
30. 30) Kim SH, Shin JW, Park SA, Kim YK, Park MS, Mok JM, Yang WI, Lee JW. Chemical, structural properties, and osteoconductive effectiveness of bone block derived from porcine cancellous bone. J Biomed Mater Res B Appl Biomater 2004; 68: 69-74.10.1002/jbm.b.10084 ↗
31. 31) Janus AM, Faryna M, Haberko K, Rakowska A, Panz T. Chemical and microstructural characterization of natural hydroxyapatite derived from pig bones. Microchimica Acta 2008; 161: 349-353.10.1007/s00604-007-0864-2 ↗
32. 32) Ooi CY, Hamdi M, Ramesh S. Properties of hydroxyapatite produced by annealing of bovine bone. Ceramics Int 2007; 33: 1171-1177.10.1016/j.ceramint.2006.04.001 ↗
33. 33) Seo DS, Lee JK. Dissolution of human teeth-derived hydroxyapatite. Ann Biomed Eng 2008; 36: 132-140.10.1007/s10439-007-9394-7 ↗
34. 34) Partanen S. Inhibition of human renal acid phosphatases by nephrotoxic micromolar concentrations of fluoride. Exp Toxicol Pathol 2002; 54: 231-237.10.1078/0940-2993-00251 ↗